ImmuneBridge logo

ImmuneBridge

San Francisco, CA

ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural ki... Read more

immunebridge.com

Company Details

Founded

2018

Employees

Between 10 - 20 employees

Raised

$17,632,000

Headquarters Location

San Francisco, CA

Public

No

Acquired

No

CEO

Peretz PartenskyPeretz Partensky

Founders

Jesse Cotari
Jesse Cotari
Peretz Partensky
Peretz Partensky

Company Collections

These are collections ImmuneBridge is a part of. Click on the collection name to view similar companies.

ImmuneBridge's Industries

ImmuneBridge's Investors

ImmuneBridge Headquarters Location

2122 Bryant St, San Francisco, CA 94110

Total Amount Raised: $17,632,000

ImmuneBridge's Investors

ImmuneBridge Funding Rounds

  • Series Unknown

    $5,632,000

  • Seed

    $12,000,000

    Seed Investors

    Insight Venture Partners
    M Ventures
    One Way Ventures
    Gaingels
Funding info provided by Diffbot.

ImmuneBridge Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ImmuneBridge.

Recent reviews